The tachykinin NK3 receptor antagonist SR142801 blocks the behavioral effects of cocaine in marmoset monkeys

European Journal of Pharmacology

Volumn 536, Issue 3, 2006, Pages 269-278

  De Souza Silva, Maria A ^a   Mello Jr , Eldon L ^b   Müller, Christian P ^a   Jocham, Gerhard ^a   Maior, Rafael S ^b   Huston, Joseph P ^a   Tomaz, Carlos ^b   Barros, Marilia ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Behavior; Cocaine; Marmoset; Sensitivity; SR 142801; Tachykinin NK3 receptor

Indexed keywords

COCAINE; NEUROKININ 3 RECEPTOR ANTAGONIST; OSANETANT; SODIUM CHLORIDE; TACHYKININ RECEPTOR ANTAGONIST; NEUROKININ 3 RECEPTOR; NEUROLEPTIC AGENT; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXPLORATORY BEHAVIOR; FEMALE; HYGIENE; LOCOMOTION; MALE; MARMOSET; MAZE TEST; NONHUMAN; ODOR; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CALLITHRIX; COCAINE; COCAINE-RELATED DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; INJECTIONS, INTRAPERITONEAL; MALE; MAZE LEARNING; MOTOR ACTIVITY; PIPERIDINES; RECEPTORS, NEUROKININ-3;

EID: 33646032686     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.010     Document Type: Article

References (47)

1. Barnes J.M., Barnes N.M., Costall B., Cox A.J., Domeney A.M., Kelly M.E., and Naylor R.J. Neurochemical consequences following injection of the substance-P analog, Dime-C7, into the rat ventral tegmental area. Pharmacol. Biochem. Behav. 37 (1990) 839-841
2. Barros M., and Tomaz C. Non-human primate models for investigating fear and anxiety. Neurosci. Biobehav. Rev. 26 (2002) 187-201
3. Barros M., Boere V., Huston J.P., and Tomaz C. Measuring fear and anxiety in the marmoset (Callithrix penicillata) with a novel predator confrontation model: effects of diazepam. Behav. Brain Res. 108 (2000) 205-211
4. Barros M., Boere V., Mello E.L., and Tomaz C. Reactions to potential predators in captive-born marmosets (Callithrix penicillata). Int. J. Primatol. 23 (2002) 443-454
5. Barros M., De Souza Silva M.A., Huston J.P., and Tomaz C. Anxiolytic-like effects of substance P fragment (SP(1-7)) in non-human primates (Callithrix penicillata). Peptides 23 (2002) 967-973
6. Barros M., Mello E.L., Maior R.S., Müller C.P., De Souza Silva M.A., Carey R.J., Huston J.P., and Tomaz C. Anxiolytic-like effects of the selective 5-HT1A receptor antagonist WAY 100635 in non-human primates. Eur. J. Pharmacol. 482 (2003) 197-203
7. Barros M., De Souza Silva M.A., Huston J.P., and Tomaz C. Multibehavioral analysis of fear and anxiety before, during, and after experimentally induced predatory stress in Callithrix penicillata. Pharmacol. Biochem. Behav. 78 (2004) 357-367
8. Barros M., Alencar C., and Tomaz C. Differences in aerial and terrestrial visual scanning in captive black tufted-ear marmosets (Callithrix penicillata) exposed to a novel environment. Folia Primatol. 75 (2004) 85-92
9. Breiter H.C., Gollub R.L., Weisskoff R.M., Kennedy D.N., Makris N., Berke J.D., Goodman J.M., Kantor H.L., Gastfriend D.R., Riorden J.P., Mathew R.T., Rosen B.R., and Hyman S.E. Acute effects of cocaine on human brain activity and emotion. Neuron 19 (1997) 591-611
10. Caine N.G. Visual scanning by tamarins-a description of the behavior and tests of 2 derived hypotheses. Folia Primatol. 43 (1984) 59-67
11. Caine N.G. Cutting costs in response to predatory threat by Geoffroy's marmosets (Callithrix geoffroyi). Am. J. Primatol. 46 (1998) 187-196
12. Conde C.A., Costa V., and Tomaz C. PROSTCOM: Un conjunto de programas para registro y procesamiento de datos comportamentales en investigaciones de fisiologia y farmacologia. Biotemas 13 (2000) 357-367
13. De Araujo J.E., Silva R.C.B., Huston J.P., and Brandao M.L. Anxiogenic effects of substance P and its 7-11 C terminal, but not the 1-7 N terminal, injected into the dorsal periaqueductal gray. Peptides 20 (1999) 1437-1443
14. Deroche-Gamonet V., Belin D., and Piazza P.V. Evidence for addiction-like behavior in the rat. Science 305 (2004) 1014-1017
15. Echeverry M., Hasenöhrl R.U., Huston J.P., and Tomaz C. Comparison of neurokinin SP with diazepam in effects on memory and fear parameters in the elevated T-maze free exploration paradigm. Peptides 22 (2001) 1031-1036
16. Eison A.S., Eison M.S., and Iversen S.D. The behavioral-effects of a novel substance-P analog following infusion into the ventral tegmental area or substantia nigra of rat-brain. Brain Res. 238 (1982) 137-152
17. Emonds-Alt X., Bichon D., Ducoux J.P., Heaulme M., Miloux B., Poncelet M., Proietto V., Van Broeck D., Vilain P., and Neliat G. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sci. 56 (1995) L27-L32
18. Ferrari S.F., and Ferrari M.A.L. Predator avoidance-behavior in the buffy-headed marmoset, Callithrix-Flaviceps. Primates 31 (1990) 323-338
19. Hardie S.M., and Buchanan-Smith H.M. Vigilance in single- and mixed-species groups of tamarins (Saguinus labiatus and Saguinus fuscicollis). Int. J. Primatol. 18 (1997) 217-234
20. Hasenöhrl R.U., Gerhardt P., and Huston J.P. Evidence for dose-dependent positively and negatively reinforcing effects of the substance P C-terminal analog DIME-C7. Neuropeptides 17 (1990) 205-211
21. Hasenöhrl R.U., Gerhardt P., and Huston J.P. Positively reinforcing effects of the neurokinin substance P in the basal forebrain: mediation by its C-terminal sequence. Exp. Neurol. 115 (1992) 282-291
22. Hasenöhrl R.U., De Souza Silva M.A., Nikolaus S., Tomaz C., Brandao M.L., Schwarting R.K.W., and Huston J.P. Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides 34 (2000) 272-280
23. Hökfelt T., Pernow B., and Wahren J. Substance P: a pioneer amongst neuropeptides. J. Intern. Med. 249 (2001) 27-40
24. Homberg J.R., van den Akker M., Raaso H.S., Wardeh G., Binnekade R., Schoffelmeer A.N.M., and De Vries T.J. Enhanced motivation to self-administer cocaine is predicted by self-grooming behaviour and relates to dopamine release in the rat medial prefrontal cortex and amygdala. Eur. J. Neurosci. 15 (2002) 1542-1550
25. Hooks M.S., Jones G.H., Smith A.D., Neill D.B., and Justice J.B. Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine. Synapse 9 (1991) 121-128
26. Huston J.P., Hasenöhrl R.U., Boix F., Gerhardt P., and Schwarting R.K.W. Sequence-specific effects of neurokinin substance-P on memory, reinforcement, and brain dopamine activity. Psychopharmacology 112 (1993) 147-162
27. Jocham, G., Lezoch, K., Müller, C.P., Kart-Teke, E., Huston, J.P., de Souza Silva, M.A., submitted for publication. Neurokinin3 receptor antagonism attenuates cocaine's behavioral activating effects yet potentiates its dopamine-enhancing action in the nucleus accumbens core.
28. Kelley A.E., Stinus L., and Iversen S.D. Behavioral activation induced in the rat by substance-P infusion into ventral tegmental area-implication of dopaminergic A10 neurons. Neurosci. Lett. 11 (1979) 335-339
29. King F.A., Yarbrough C.J., Anderson D.C., Gordon T.P., and Gould K.G. Primates. Science 240 (1988) 1475-1482
30. Koenig A. Visual scanning by common marmosets (Callithrix jacchus): functional aspects and the special role of adult males. Primates 39 (1998) 85-90
31. Krappmann P., Hasenöhrl R.U., Frisch C., and Huston J.P. Self-administration of neurokinin substance P into the ventromedial caudate-putamen in rats. Neuroscience 62 (1994) 1093-1101
32. Kronenberg G., Berger P., Tauber R.F., Bandelow B., Henkel V., and Heuser I. Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challenges. Pharmacopsychiatry 38 (2005) 24-29
33. Massi M., Panocka I., and de Caro G. The psychopharmacology of tachykinin NK-3 receptors in laboratory animals. Peptides 21 (2000) 1597-1609
34. Mello E.L., Maior R.S., Carey R.J., Huston J.P., Tomaz C., and Müller C.P. Serotonin(1A)-receptor antagonism blocks psychostimulant properties of diethylpropion in marmosets (Callithrix penicillata). Eur. J. Pharmacol. 511 (2005) 43-52
35. Müller C.P., Carey R.J., and Huston J.P. Serotonin as an important mediator of cocaine's behavioral effects. Drugs Today 39 (2003) 497-511
36. Nguyen-Le X.K., Nguyen Q.T., Gobeil F., Pheng L.H., Emonds-Alt X., Breliere J.C., and Regoli D. Pharmacological characterization of SR 142801: a new non-peptide antagonist of the neurokinin NK-3 receptor. Pharmacology 52 (1996) 283-291
37. Nikolaus S., Huston J.P., and Hasenöhrl R.U. Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P. Neurosci. Lett. 283 (2000) 37-40
38. Regoli D., Boudon A., and Fauchere J.L. Receptors and antagonists for substance P and related peptides. Pharmacol. Rev. 46 (1994) 551-599
39. Ribeiro S.J., and De Lima T.C.M. Naloxone-induced changes in tachykinin NK3 receptor modulation of experimental anxiety in mice. Neurosci. Lett. 258 (1998) 155-158
40. Ribeiro S.J., Teixeira R.M., Calixto J.B., and De Lima T.C.M. Tachykinin NK3 receptor involvement in anxiety. Neuropeptides 33 (1999) 181-188
41. Rogerio R., and Takahashi R.N. Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze. Pharmacol. Biochem. Behav. 43 (1992) 631-633
42. Stevenson M.F., and Poole T.B. Ethnogram of common marmoset (Calithrix-Jacchus-Jacchus)-general behavioral repertoire. Anim. Behav. 24 (1976) 428-451
43. Stevenson M.F., and Rylands A.B. The marmosets, genus Callithrix. In: Mittermeier R.A., Rylands A.B., Coimbra-Filho A., and Fonseca G.A.B. (Eds). Ecology and Behavior of Neotropical Primates (1988) 131-222
44. Stoessl A.J., Dourish C.T., and Iversen S.D. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behavior following central or peripheral administration in mice and rats. Br. J. Pharmacol. 94 (1988) 285-287
45. Vanderschuren L.J.M.J., and Everitt B.J. Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305 (2004) 1017-1019
46. Volkow N.D., Wang G.J., Fischman M.W., Foltin R.W., Fowler J.S., Abumrad N.N., Vitkun S., Logan J., Gatley S.J., Pappas N., Hitzemann R., and Shea C.E. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386 (1997) 827-830
47. Yang X.M., Gorman A.L., Dunn A.J., and Goeders N.E. Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies. Pharmacol. Biochem. Behav. 41 (1992) 643-650